Statement Of Changes In Equity [Abstract]

BerGenBio - Filing #2542730

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity	—	127,476,000 NOK	189,234,000 NOK	—	—	854,000 NOK	—	268,869,000 NOK	—	46,987,000 NOK	88,498,000 NOK	—	—	—	35,780,000 NOK	0 NOK	8,866,000 NOK	43,852,000 NOK	—	—	0 NOK	40,386,000 NOK	384,426,000 NOK	335,195,000 NOK	8,846,000 NOK
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)	190,401,000 NOK	—	—	190,401,000 NOK	0 NOK	—	0 NOK	—	0 NOK	—	—	0 NOK	302,122,000 NOK	0 NOK	—	—	—	—	302,122,000 NOK	0 NOK	—	—	—	—	—
Comprehensive income	189,234,000 NOK	—	—	189,234,000 NOK	0 NOK	—	0 NOK	—	0 NOK	—	—	0 NOK	302,606,000 NOK	0 NOK	—	—	—	—	302,606,000 NOK	0 NOK	—	—	—	—	—
Issue of equity	262,048,000 NOK	—	—	0 NOK	2,045,000 NOK	—	260,003,000 NOK	—	0 NOK	—	—	21,000 NOK	3,218,000 NOK	0 NOK	—	—	—	—	3,198,000 NOK	0 NOK	—	—	—	—	—
Increase (decrease) through share-based payment transactions, equity	3,135,000 NOK	—	—	0 NOK	0 NOK	—	0 NOK	—	3,135,000 NOK	—	—	0 NOK	3,466,000 NOK	0 NOK	—	—	—	—	0 NOK	3,466,000 NOK	—	—	—	—	—